Good morning :)
$
₹
I

iTonic Holdings Ltd.

ITOC

NASDAQ
I

iTonic Holdings Ltd.

ITOC

NASDAQ
$0.317.25% (+0.02)
$
₹
$0.317.25% (+0.02)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Medical Devices

Micro Cap

With a market cap of $7.5M the stock is ranked 5829

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

0.82
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-0.32
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

0%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Company Profile

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.
iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.

Peers

Peers

Veeva Systems Inc Class A
VEEV
Veeva Systems Inc Class A
P/E Ratio
43.35
43.35
1Y Return
6.76%
6.76%
Buy Reco %
59.37
59.37
Waystar Holding Corp. Common Stock
WAY
Waystar Holding Corp. Common Stock
P/E Ratio
37.98
37.98
1Y Return
33.48%
33.48%
Buy Reco %
100.00
100.00
Doximity Inc
DOCS
Doximity Inc
P/E Ratio
30.88
30.88
1Y Return
63.89%
63.89%
Buy Reco %
42.10
42.10
Inspire Medical Systems Inc
INSP
Inspire Medical Systems Inc
P/E Ratio
16.45
16.45
1Y Return
12.78%
12.78%
Buy Reco %
72.22
72.22
Schrodinger Inc
SDGR
Schrodinger Inc
P/E Ratio
—
—
1Y Return
47.68%
47.68%
Buy Reco %
75.00
75.00

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Devices

Valuation

Returns

Forecast

StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
iTonic Holdings Ltd. -0.82-
Veeva Systems Inc Class A43.355.801.18
Waystar Holding Corp. Common Stock37.981.28-

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

0.2
-0.2
0.2
-0.3
0
-2
0.4
-3
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Revenue
Net Income
Financial YearQ2 2022Q4 2022Q2 2023Q4 2023Q2 2024Q4 2024Q2 2025Q4 2025
Total Revenue0.380.290.260.360.210.230.060.45
Net Income0.070.01-0.08-0.15-0.28-0.37-2.03-3.06
Net Profit Margin18.48%4.23%-31.33%-43.56%-135.46%-157.94%-3018.19%-671.84%
See CostsAll values in $ Million

Frequently asked questions

Frequently asked questions

  1. iTonic Holdings Ltd. (ITOC) share price today is $0.31 as of September 19, 2026 at 1:30 AM IST. The stock touched a day high of $0.44 and a day low of $0.28.

  2. iTonic Holdings Ltd. stock trades on NASDAQ under the ticker symbol ITOC.

  3. iTonic Holdings Ltd.'s market capitalization is $7.48M as of September 19, 2026 at 1:30 AM IST.

  4. iTonic Holdings Ltd.'s price-to-earnings (P/E) ratio is N/A as of September 18, 2026.

  5. iTonic Holdings Ltd.'s price-to-book (P/B) ratio is 0.82 as of September 18, 2026.

  6. Yes, You can buy iTonic Holdings Ltd. shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy iTonic Holdings Ltd. shares in three steps: 1. Search iTonic Holdings Ltd. on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since iTonic Holdings Ltd. trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in iTonic Holdings Ltd. (ITOC) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 31.4465 shares at the current price of $0.31.

Loading...